Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Return on Capital Employed data on record, last reported at 0.05% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 30.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.05%, up 30.0%, while the annual FY2025 figure was 0.11%, 36.0% up from the prior year.
  • Return on Capital Employed reached 0.05% in Q4 2025 per PTCT's latest filing, down from 0.4% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.45% in Q1 2025 and bottomed at 0.8% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 0.2%, with a median of 0.25% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: tumbled -54bps in 2023, then surged 74bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then crashed by -42bps to 0.36% in 2022, then dropped by -24bps to 0.45% in 2023, then soared by 44bps to 0.25% in 2024, then surged by 118bps to 0.05% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.05% in Q4 2025, 0.4% in Q3 2025, and 0.34% in Q2 2025.